Response to ASX Query Letter
Filed with ASX · · 14 pages · English
Summary by 6ix AI
This filing is a response to an ASX query letter regarding 4DMedical Ltd.'s disclosures related to recent agreements with Stanford University and other institutions. The company explains that it believes its announcements adequately described the significance of these agreements without including financial information, as the agreements do not guarantee minimum revenue. The company asserts that it has not engaged in any ramping conduct and has fulfilled its continuous disclosure obligations.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from 4DMedical
- University of Chicago Medicine adopts CTVQ
- Quarterly Activity Report and Appendix 4C
- 4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging
- 4DMedical completes $150 million institutional placement
- Trading Halt
Later from 4DMedical
- Appendix 4D and FY26 Half Year Report
- S&P DJI Announces March 2026 Quarterly Rebalance
- Update - S&P DJI March 2026 Rebalance of the All Ordinaries
- CTVQ deployed at Mayo Clinic
- CE Mark for CTVQ and $83M placement to fund EU expansion
Follow 4DMedical into a list and get an email when it puts out news.
Follow 4DMedical